Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun:69:507-512.
doi: 10.1016/j.breast.2023.04.001. Epub 2023 Apr 13.

The effect of silencing the Tip60 gene on the response to radiotherapy in breast cancer cells

Affiliations

The effect of silencing the Tip60 gene on the response to radiotherapy in breast cancer cells

Ece Miser-Salihoğlu et al. Breast. 2023 Jun.

Abstract

Since patients with triple-negative breast cancer do not respond to hormone therapy, the main treatment method is the combination of chemotherapy and radiotherapy. Because the DNA of the tumor cell is the target in both some chemotherapeutics and radiotherapy, problems may occur in individuals with a high DNA repair pathway. It is suggested that high expression of the Tip60 gene, which has an important role in repairing DNA damage, will increase the repair of DNA double-strand breaks in tumor cells, especially during radiotherapy treatment, thus reducing the response to treatment and adversely affecting treatment. In this study, for the first time, the role of the silenced and active Tip60 gene in response to radiotherapy in MDA-MB-231 and MCF-7 cells was investigated. For this purpose, the Tip60 gene was silenced by applying siRNA to the cell lines and UV was applied. In the study, cytotoxicity and DNA breaks were measured by MTT and COMET methods, and mRNA and protein expression values were measured by PCR and Raman spectrophotometer in silenced, unsilenced, UV-treated, and non-UV-treated cell lines. According to the results of the study, increased DNA damage was observed in MCF-7 cell lines in which the Tip60 gene was silenced, and radiotherapy was applied, compared to the cell lines with the Tip60 gene active. It was observed that DNA damage in MDA-MB-231 cell lines was less than in cell lines with the active Tip60 gene.

Keywords: Comet; MCF-7; MDA-MB-231; MTT; PCR; Protein expression; Tip60; siRNA.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that there is no conflict of interest that could be perceived as prejudicial to the impartiality of the reported research.

Figures

Fig. 1
Fig. 1
PCR amplification plots of β-ACTB andTip60. A and B. β-ACTB, C. unsilenced Tip60, D. silenced Tip60 gene.
Fig. 2
Fig. 2
Relative evaluation of the cells with the 2−ΔΔCt method by normalizing the expression levels of Tip60 in cell lines with and without the tip60 gene silenced.
Fig. 3
Fig. 3
Protein analysis results by Surface Enriched Raman Spectroscopy in MCF-7 and MDA-MB-231 cell lines.
Fig. 4
Fig. 4
Percentage of viability in MCF 7 and MDA-MB-231 cell lines after silencing of the Tip60 gene and before and after UV treatment.
Fig. 5
Fig. 5
DNA damage in MCF-7 and MDA-MB 231 cells was examined by comet assays. The results show DNA damage in cells in terms of tail density.
Fig. 6
Fig. 6
Comet images of UV-treated MCF-7 cells with the Tip60 gene activated.
Fig. 7
Fig. 7
A. Comet images of MDA-MB- 231 cell with activated Tip60 gene and UV-treated, B. Comet images of Tip60 gene silenced and UV-treated MDA-MB- 231 cell.

Similar articles

References

    1. Goldhirsch A., et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen international expert Consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 2011;22(8) 1736-47. - PMC - PubMed
    1. Kang H.S., et al. Diffusion kurtosis MR imaging of invasive breast cancer: correlations with prognostic factors and molecular subtypes. J Magn Reson Imag. 2022;56(1):110–120. - PubMed
    1. Xiao Y., Gao W. Therapeutic pattern and progress of neoadjuvant treatment for triple-negative breast cancer (Review) Oncol Lett. 2022;24(1):219. - PMC - PubMed
    1. Sadzevičienė I., et al. Recurrent germline BRCA2 gene mutation in Lithuanian family. Medicina (Kaunas) 2020;56(3) - PMC - PubMed
    1. Baskar R., et al. Biological response of cancer cells to radiation treatment. Front Mol Biosci. 2014;1:24. - PMC - PubMed